脱细胞真皮基质在腭成形术中预防口鼻瘘的系统综述与荟萃分析
该系统综述与荟萃分析检索2016年7月至2024年6月PubMed、Embase、Cochrane和OVID文献,纳入8项比较腭成形术中使用与不使用脱细胞真皮基质(ADM)的研究。单用本荟萃分析未发现ADM显著降低术后口鼻瘘风险,但合并最近一项荟萃分析数据后风险显著降低47%;合并数据中原发和继发腭修复的瘘复发合并比例为6.58%。结论认为ADM可作为腭成形术减少口鼻瘘的可靠辅助手段。
要点
- ADM用于原发和继发腭成形术可显著降低术后口鼻瘘复发风险。
- 单独本荟萃分析未显示显著降低,合并最新荟萃分析后风险降低47%。
- 合并数据中瘘复发合并比例为6.58%,优于既往使用ADM的研究。
核心结论
- 使用ADM进行原发和继发腭成形术可显著降低术后口鼻瘘复发,ADM可作为减少口鼻瘘风险的可靠辅助手段。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Embase、Cochrane和OVID于2016年7月至2024年6月发表的比较腭成形术中使用与不使用ADM的研究。
- 纳入8项符合标准的研究,由两名独立研究者使用Covidence筛选。
主要发现
- 单独本荟萃分析发现使用ADM降低术后瘘形成的相对风险降低不显著。
- 与最近一项荟萃分析数据合并后,发现统计学显著降低,ADM使发生瘘的风险降低47%。
- 合并数据中,原发和继发腭修复的瘘复发合并比例为6.58%。
临床怎么用
- 在原发和继发腭成形术中可考虑使用ADM作为辅助手段以降低口鼻瘘风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aims of the study were to update the current trends in acellular dermal matrix (ADM) utilization during palatoplasty procedures and to evaluate its effectiveness in reducing postoperative oronasal fistula formation. DESIGN: This is a systematic review and meta-analysis. PATIENTS OR PARTICIPANTS: Patients undergoing primary or secondary cleft palate repair. INTERVENTIONS: A comprehensive literature search was conducted via PubMed, Embase, Cochrane, and OVID for relevant studies published between July 2016 and June 2024 involving patients undergoing primary or secondary cleft palate repair with ADM versus without. All records were screened by two independent investigators using Covidence. Studies were excluded if they were not published in English, did not use ADM, were nonhuman, or had no reported outcome. MAIN OUTCOME MEASURES: Postoperative oronasal fistula formation. RESULTS: Eight studies met the inclusion criteria. This meta-analysis alone found a nonsignificant decrease in relative risk reduction of postoperative fistula formation with the use of ADM; however, when combined with data from the most recent meta-analysis, a statistically significant decrease was found. Overall, the addition of ADM resulted in 47% lower risk of developing fistulas. Furthermore, with the combined data, the pooled proportion of fistula recurrence for primary and secondary palate repair was 6.58%, which is favorable compared to previous studies' rates with the use ADM. CONCLUSIONS: This systematic review found a statistically significant decrease in postoperative fistula recurrence when using ADM for both primary and secondary palatoplasty. Therefore, ADM can be considered as a reliable adjunct to palatoplasty for reducing the risk of oronasal fistulas.
引用
- Clifton WR, Stager JC, Clifton EV, et al. Prevention of Oronasal Fistula Formation in Palatoplasty With Acellular Dermal Matrix: A Systematic Review and Meta-analysis. Ann Plast Surg. 2025. PMID: 40864608. doi:10.1097/SAP.0000000000004483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。